These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17572996)

  • 1. [Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease].
    Peng M; Cai BQ; Ma Y; Zhu HJ; Sun Q; Song AL
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):182-5. PubMed ID: 17572996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating ghrelin in patients with chronic obstructive pulmonary disease.
    Luo FM; Liu XJ; Li SQ; Wang ZL; Liu CT; Yuan YM
    Nutrition; 2005; 21(7-8):793-8. PubMed ID: 15975486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ghrelin and leptin in adult cystic fibrosis patients.
    Cohen RI; Tsang D; Koenig S; Wilson D; McCloskey T; Chandra S
    J Cyst Fibros; 2008 Sep; 7(5):398-402. PubMed ID: 18353734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
    Yang YM; Sun TY; Liu XM
    Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
    Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
    Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
    Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH
    Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
    Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
    Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X; Ji Y; Chen J; Li S; Luo F
    Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum zinc, plasma ghrelin, leptin levels, selected biochemical parameters and nutritional status in malnourished hemodialysis patients.
    Sahin H; Uyanik F; Inanç N; Erdem O
    Biol Trace Elem Res; 2009 Mar; 127(3):191-9. PubMed ID: 18953507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum resistin and leptin in patients with chronic obstructive pulmonary disease and their relationship to nutritional state].
    Wang QY; Zhang H; Yan X; Kang J; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):445-7. PubMed ID: 16115391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary investigation of effect of serum leptin on nutritional state of COPD patients].
    Yuan Y; Wang Z; Liu C
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 May; 23(5):292-5. PubMed ID: 11778221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The changes of ghrelin, growth hormone, growth hormone releasing hormone and their clinical significances in patients with chronic obstructive pulmonary disease].
    Xu ZS; Bao ZY; Wang ZY; Yang GJ; Zhu DF; Zhang L; Tan RM
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):536-9. PubMed ID: 22943826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating leptin and the trophological status of patients with chronic obstructive pulmonary disease].
    Beloborodova EI; Akimova LA; Asanova AV; Burkovskaia VA; Kritskaia NG
    Ter Arkh; 2010; 82(3):8-13. PubMed ID: 20564913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignancies.
    Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Neubauer K; Kustrzeba-Wojcicka I; Terlecki G; Gamian A
    Exp Oncol; 2008 Mar; 30(1):75-80. PubMed ID: 18438346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease.
    Eker S; Ayaz L; Tamer L; Ulubas B
    Scand J Clin Lab Invest; 2010 Feb; 70(1):40-4. PubMed ID: 20021311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating leptin and body composition in chronic obstructive pulmonary disease.
    Karakas S; Karadag F; Karul AB; Gurgey O; Gurel S; Guney E; Cildag O
    Int J Clin Pract; 2005 Oct; 59(10):1167-70. PubMed ID: 16178984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
    Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
    Ju CR; Chen RC
    Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.